| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5703495 | Archivos de la Sociedad Española de Oftalmología | 2017 | 8 Pages |
Abstract
Aflibercept in TAE is effective for all exudative-AMD subtypes. No significant differences in patient's visual gain, mean number of injections, or number of visits needed were found among the subtypes of CNV.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
V. Castro-Navarro, E. Cervera-Taulet, J. Montero-Hernández, C. Navarro-Palop,